PORTLAND, Ore., April 7, 2015 /PRNewswire/ -- TriStar
Wellness Solutions, Inc. (OTCQB: TWSI), a health and wellness
company that targets opportunities in the advanced wound care
marketplace, through its subsidiary, HemCon Medical Technologies,
Inc has received regulatory approval from the China Food and Drug
Administration (CFDA) to market and sell products into China. HemCon has commercially entered the
market this month by accepting an order through a distributor on
the mainland. HemCon's launch into the Chinese market will
include its full portfolio of wound care solutions which are
protected by patents both in China
and throughout the world. Currently the wound care market in
China is estimated at $1.2 billion.
Photo - http://photos.prnewswire.com/prnh/20150406/196695
Photo - http://photos.prnewswire.com/prnh/20150406/196696
HemCon has prior experience in the pan-Asian market having
successfully established a wound care product line in Japan with their partner ZERIA
Pharmaceutical.
Michael Wax, President and CEO
said, "With our initial Chinese order in hand, combined with the
Chinese government's approval for import of our dressings, we are
looking ahead to building a robust business in a rapidly growing
market. We have expectations to participate in the fast growing
pan-Asian health care industry and specifically the increasing
demand for wound care in China."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops,
manufactures, and markets innovative technologies for hemostatic
devices for the control of bleeding resulting from trauma or
surgery. HemCon products are designed for use by military and
civilian first responders as well as medical professionals in
hospital and clinical settings where control of bleeding are of
critical importance. HemCon is headquartered in Portland, Ore. The Company has subsidiaries in
Ireland and the Czech Republic. For more information, please
visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (OTCQB:TWSI) is a health and
wellness company that targets opportunities in the advanced wound
care marketplace. TriStar is the owner of HemCon Medical
Technologies Inc., a company dedicated to saving lives through
innovative wound care solutions.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc.
contains forward-looking statements. Generally, you can identify
these statements because they use words like "anticipates,"
"believes," "expects," "future," "intends," "plans," and similar
terms. These statements reflect only our current expectations.
Although we do not make forward-looking statements unless we
believe we have a reasonable basis for doing so, we cannot
guarantee their accuracy and actual results may differ materially
from those we anticipated due to a number of uncertainties, many of
which are unforeseen, including, among others, the risks we face as
described our filings with the Securities and Exchange Commission.
You should not place undue reliance on these forward-looking
statements which apply only as of the date of this press release.
To the extent that such statements are not recitations of
historical fact, such statements constitute forward-looking
statements that, by definition, involve risks and uncertainties. In
any forward-looking statement where we express an expectation or
belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis,
but there can be no assurance that the statement of expectation of
belief will be accomplished.
Contact:
Stephanie
Wiegman
Tel: (503)
245-0459
Email
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hemcon-medical-technologies-launches-into-chinese-market-300061723.html
SOURCE TriStar Wellness Solutions, Inc.
